Rangelov, BA;
Young, AL;
Jacob, J;
Cahn, AP;
Lee, S;
Wilson, FJ;
Hawkes, DJ;
(2020)
Thoracic Imaging at Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review.
International Journal of Chronic Obstructive Pulmonary Disease
, 2020
(15)
pp. 1751-1787.
10.2147/copd.s250746.
Preview |
Text
copd-250746-thoracic-imaging-at-exacerbation-of-chronic-obstructive-pulm.pdf - Published Version Download (824kB) | Preview |
Abstract
Exacerbations of chronic obstructive pulmonary disease (COPD) are currently diagnosed based on changes in respiratory symptoms. Characterizing the imaging manifestation of exacerbations could be useful for objective diagnosis of exacerbations in the clinic and clinical trials, as well as provide a mechanism for monitoring exacerbation treatment and recovery. In this systematic review, we employed a comprehensive search across three databases (Medline, EMBASE, Web of Science) to identify studies that performed imaging of the thorax at COPD exacerbation. We included 51 from a total of 5,047 articles which met all our inclusion criteria. We used an adapted version of the Modified Newcastle-Ottawa Quality Assessment Scale for cohort studies to assess the quality of the included studies. Conclusions were weighted towards higher-quality articles. We identified a total of 36 thoracic imaging features studied at exacerbation of COPD. Studies were generally heterogeneous in their measurements and focus. Nevertheless, considering studies which performed consecutive imaging at stable state and exacerbation, which scored highest for quality, we identified salient imaging biomarkers of exacerbations. An exacerbation is characterized by airway wall and airway calibre changes, hyperinflation, pulmonary vasoconstriction and imaging features suggestive of pulmonary arterial hypertension. Most information was gained from CT studies. We present the first ever composite imaging signature of COPD exacerbations. While imaging during an exacerbation is comparatively new and not comprehensively studied, it may uncover important insights into the acute pathophysiologic changes in the cardiorespiratory system during exacerbations of COPD, providing objective confirmation of events and a biomarker of recovery and treatment response.
Archive Staff Only
 |
View Item |
